Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Consumer Science at the UFS awards three PhDs
2015-07-08

Dr Gloria Seiphetlheng, Dr Natasha Cronje, Dr Ismari van der Merwe and Prof Hester Steyn.
Photo: Leonie Bolleurs

For the first time in its history, the Department of Consumer Science in the Faculty of Natural and Agricultural Sciences at the University of the Free State (UFS) earned three doctorates at one graduation ceremony this year. This week three PhDs were awarded to Ismari van der Merwe, Natasha Cronje, and Gloria Seiphetlheng at the Winter Graduation that took place on the Bloemfontein Campus.

Electrochemically-activated water is widely used in the food and other industries, due to its excellent environment-friendly properties. However, it is not used in the textile industry yet, because too little research has been done to determine the possible positive and negative impact it may have on textiles.

With the thesis, The evaluation of catholyte treatment on the colour and tensile properties of dyed cotton, polyester and polyamide 6,6 fabrics,  Dr Cronje, a lecturer in the UFS’s Department of Consumer Science, and Dr Seiphetlheng from the Serowe College of Education in Botswana,  provided major new information with the thesis, Anolyte as an alternative bleach for cotton fabrics. This information is essential when considering the application of catholytes and anolytes in the textile industry.

Electrochemically-activated water divides water in catholytes and anolytes. The anolyte part is used as a disinfectant and bleach. It is not really suitable for domestic use, as it can cause colour loss in coloured textile products. However, it can be used in the hospitality industry where white sheets, towels, etc., are used and washed on a regular basis.

The catholyte part of the water has properties similar to washing powder. It can also be used in the textile industry as washing liquid.

According to Prof Hester Steyn, Head of the Department of Consumer Science and supervisor of all three PhD candidates, this electrochemically-activated water is also very eco-friendly. “It has a short shelf life. If the electrochemically-activated water isn’t utilised, it returns to normal water that wouldn’t harm the environment. No water is therefore lost, and no waste products are released that would contaminate the environment,” she says.

Dr Van der Merwe’s research focused on Degumming Gonometa postica cocoons using environmentally conscious methods. A lecturer in the Department of Consumer Science, she demonstrated that simple and environmentally-friendly methods can be used with great success to procure wild silk from the cocoons of the Gonometa postica worms living in the camel thorn trees found in the Northern Cape and Namibia.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept